-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Eiger BioPharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
- Eiger BioPharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending December 31, 2023 was -49.4 USD/shares, a 27.4% increase year-over-year.
- Eiger BioPharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending December 31, 2023 was -50.8 USD/shares, a 27.2% increase year-over-year.
- Eiger BioPharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -50.8 USD/shares, a 27.2% increase from 2022.
- Eiger BioPharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -69.7 USD/shares, a 6874% decline from 2021.
- Eiger BioPharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -1 USD/shares, a 56.7% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)